Insulin-Like Growth Factor Inhibition In Lung Cancer

Published: April 6, 2009, 1:03 p.m.

b'Oncology Times Broadcast News with the Audio Journal of Oncology\\n\\nReporting from: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical Oncology\\n\\nInsulin-Like Growth Factor Inhibition In Lung Cancer\\n\\nSilvia Novello, and Giorgio Scagliotti from the University of Turin about harnessing insulin-like growth factor receptor inhibition in a phase II study which has shown clinical activity of figitumomab at least as significant as inhibitors of other growth factors already being used in cancer.'